CAS 122648-99-1|9,10-Di(2-naphthyl)anthracene
| Common Name | 9,10-Di(2-naphthyl)anthracene | ||
|---|---|---|---|
| CAS Number | 122648-99-1 | Molecular Weight | 430.539 |
| Density | 1.2±0.1 g/cm3 | Boiling Point | 595.4±45.0 °C at 760 mmHg |
| Molecular Formula | C34H22 | Melting Point | 382-384ºC |
| MSDS | ChineseUSA | Flash Point | 314.8±22.8 °C |
| Symbol | GHS07 | Signal Word | Warning |
Names
| Name | 9,10-Bis(2-naphthyl)anthrace |
|---|---|
| Synonym | More Synonyms |
Chemical & Physical Properties
| Density | 1.2±0.1 g/cm3 |
|---|---|
| Boiling Point | 595.4±45.0 °C at 760 mmHg |
| Melting Point | 382-384ºC |
| Molecular Formula | C34H22 |
| Molecular Weight | 430.539 |
| Flash Point | 314.8±22.8 °C |
| Exact Mass | 430.172150 |
| LogP | 10.66 |
| Vapour Pressure | 0.0±0.8 mmHg at 25°C |
| Index of Refraction | 1.761 |
Safety Information
| Symbol | GHS07 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H302 |
| Hazard Codes | Xn |
| Risk Phrases | R36/37/38 |
| Safety Phrases | 36/37/38 |
| RIDADR | NONH for all modes of transport |
Articles6
More Articles| Biosynthesis of cell envelope-associated phenolic glycolipids in Mycobacterium marinum. J. Bacteriol. 197(6) , 1040-50, (2015) Phenolic glycolipids (PGLs) are polyketide synthase-derived glycolipids unique to pathogenic mycobacteria. PGLs are found in several clinically relevant species, including various Mycobacterium tuberc... | |
| Adenosine conjugated lipidic nanoparticles for enhanced tumor targeting. Int. J. Pharm. 486 , 287-96, (2015) Delivering chemotherapeutics by nanoparticles into tumor is impeded majorly by two factors: nonspecific targeting and inefficient penetration. Targeted delivery of anti-cancer agents solely to tumor c... | |
| Genetic and chemical validation identifies Mycobacterium tuberculosis topoisomerase I as an attractive anti-tubercular target. Tuberculosis (Edinb.) 95 , 589-98, (2015) DNA topoisomerases perform the essential function of maintaining DNA topology in prokaryotes. DNA gyrase, an essential enzyme that introduces negative supercoils, is a clinically validated target. How... |
Synonyms
| 9,10-Di(naphthalen-2-yl)anthracen |
| 9,10-Di(naphthalen-2-yl)anthracene |
| 9,10-dinaphthalen-2-ylanthracene |
| Anthracene, 9,10-di-2-naphthalenyl- |
| 9,10-Di-2-naphthalenyl-anthracene,ADN |
| MFCD00028944 |
| 9,10-Di(2-naphthyl)anthracene |
| 9,10-Di(naphth-2-yl)anthracene |
